Physician profile
Jorge J Rivera
NPI 1053317263
$1,811.34
in general payments reported to CMS, 2019-2025
14 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $174 · 2021: $85.09 · 2022: $189 · 2023: $209 · 2024: $496 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $522.67 | 2022-2025 | Rocklatan, Argos, Eysuvis |
| Abbvie INC. | $349.34 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Allergan, INC. | $240.93 | 2019-2022 | |
| New World Medical,INC. | $178.22 | 2023-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Harrow Eye, LLC | $92.60 | 2024 | Iheezo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $91.62 | 2019-2021 | |
| Glaukos Corporation | $82.15 | 2025 | Idosetr |
| Dompe US, INC. | $73.24 | 2019-2025 | Oxervate |
| Rayner Intraocular Lenses Limited | $56.43 | 2022 | |
| Sun Pharmaceutical Industries INC. | $37.37 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $29.68 | 2024 | Xdemvy |
| Biotissue Holdings INC. | $23.19 | 2024 | |
| Aerie Pharmaceuticals, INC. | $18.20 | 2019 | |
| Omeros Corporation | $15.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.